Experimental drug allowed for AIDS-related eye infections.(cidofir authorized to treat relapsing cytomegalovirus retinitis)(Brief Article) From: FDA Consumer | Date: November 1, 1995 | COPYRIGHT 1995 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Under a treatment IND recently authorized by FDA, doctors may use the investigational drug intravenous Vistide (cidofovir) to treat HIV-infected patients with relapsing cytomegalovirus (CMV) retinitis that has progressed despite treatment.

CMV retinitis is an eye infection that can lead to blindness in people with impaired immune systems, such as AIDS patients.

FDA established the Treatment IND (investigational new drug) process for patients suffering from serious o...

Related newspaper, magazine, and journal articles from HighBeam Research

	Race and The Treatment of Cytomegalovirus Retinitis in A Cohort of Patients With Acquired Immunodeficiency Syndrome Journal of the National Medical Association ; This historical cohort study assessed the impact of race on critical factors in the diagnosis and drug treatment of cytomegalovirus (CMV) retinitis in acquired immunodeficiency syndrome (AIDS) patients over a 7-year period. The study subjects included 194 adult patients with a history of AIDS who
	CMV retinitis treatment responding to changing HIV therapy Ophthalmology Times ; Discussion Uveitis Update Roundtable participants: James P. Dunn Jr., MD Associate professor of ophthalmology, The Wilmer Ophthalmological Institute, Division of Ocular Immunology, Baltimore William R. Freeman, MD Professor of ophthalmology, department of ophthalmology, UCSD School of Medicine,
	CMV retinitis presents a changing clinical picture Ophthalmology Times ; COLE EYE INSTITUTE SYMPOSIUM AIDS epidemic has increased frequency; newer drugs have altered treatment approach CLEVELAND-Cytomegalovirus (CMV) retinitis is a disease in transition, and a new chapter in its history is beginning, Gary N. Holland, MD, said in a presentation at the dedication of the
	New CMV treatments finally arriving for HIV patients Drug Topics ; Treatment for cytomegalovirus (CMV) infection in HIV patients is finally getting easier. In October, the Food & Drug Administration expanded the indication for oral ganciclovir (Cytovene, Roche Bioscience) to include prevention of CMV, including CMV retinitis, in advanced AIDS patients. The
	What does the future hold? Ophthalmology Times ; Specilaists from around the country review the latest treatment strategies, new areas of research Researchers presented new strategies for tackling numerous retinal diseases that can have devastating effects on vision in a symposium entitled "New Vessels, New Medicines, New Ideas in Retina. " Great

See all results.